Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Adam H. Balen & Richard A. Anderson. (2007) Impact of Obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines. Human Fertility 10:4, pages 195-206.
Read now
Read now
Adam Balen. (2003) Ovulation induction — Optimizing results and minimizing risks. Human Fertility 6:sup2, pages S42-S51.
Read now
Read now
Articles from other publishers (34)
Negin Nikrad, Abnoos Mokhtari Ardekani, Mahdieh Abbasalizad Farhangi, Ayda Zahiri Tousi, Fatemeh Pourteymour Fard Tabrizi, Maryam Vaezi & Salar Hemmati. (2023) The Effect of Thylakoid Membranes of Spinach Extract Supplementation on Atherogenic, Glycemic, and Anthropometric Indices and Renal Function in Obese PCOS Women under a Hypo-Caloric Diet: A Randomized, Double-Blind, Controlled Trial. Journal of Food Biochemistry 2023, pages 1-13.
Crossref
Crossref
Dalal Kojok, Ghina Ghazeeri & Johnny T. Awwad. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
233
253
.
Abigail Sharpe, Lara C Morley, Thomas Tang, Robert J Norman & Adam H Balen. (2019) Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Romualdi Daniela, Immediata Valentina, De Cicco Simona, Tagliafem Valeria & Lanzone Antonio. (2018) Neuroendocrine Regulation of Food Intake in Polycystic Ovary Syndrome. Reproductive Sciences 25:5, pages 644-653.
Crossref
Crossref
Lara C Morley, Thomas Tang, Ephia Yasmin, Robert J Norman & Adam H Balen. (2017) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews 2018:2.
Crossref
Crossref
Adam H Balen. (2017) Polycystic ovary syndrome (PCOS). The Obstetrician & Gynaecologist 19:2, pages 119-129.
Crossref
Crossref
Lourdes Ibáñez, Sharon E. Oberfield, Selma Witchel, Richard J. Auchus, R. Jeffrey Chang, Ethel Codner, Preeti Dabadghao, Feyza Darendeliler, Nancy Samir Elbarbary, Alessandra Gambineri, Cecilia Garcia Rudaz, Kathleen M. Hoeger, Abel López-Bermejo, Ken Ong, Alexia S. Peña, Thomas Reinehr, Nicola Santoro, Manuel Tena-Sempere, Rachel Tao, Bulent O. Yildiz, Haya Alkhayyat, Asma Deeb, Dipesalema Joel, Reiko Horikawa, Francis de Zegher & Peter A. Lee. (2017) An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence. Hormone Research in Paediatrics 88:6, pages 371-395.
Crossref
Crossref
Johnny T. Awwad & Ghina Ghazeeri. 2014. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
165
180
.
Miguel A. Velazquez & Tom P. Fleming. 2013. Oogenesis. Oogenesis
329
351
.
Kiran Nandalike, Chhavi Agarwal, Temima Strauss, Susan M. Coupey, Carmen R. Isasi, Sanghun Sin & Raanan Arens. (2012) Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome. Sleep Medicine 13:10, pages 1307-1312.
Crossref
Crossref
Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin & Adam H Balen. (2012) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Adam Balen. 2011. Gynaecology. Gynaecology
251
264
.
V. Rafael Silva. (2010) Síndrome de ovario poliquístico e infertilidad. Revista Médica Clínica Las Condes 21:3, pages 387-396.
Crossref
Crossref
Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin & Adam H Balen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Shilpi PandeySiladitya Bhattacharya. (2010) Impact of Obesity on Gynecology. Women's Health 6:1, pages 107-117.
Crossref
Crossref
Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin & Adam H Balen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin & Adam H Balen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Stefano Palomba, Angela Falbo, Fulvio Zullo & Francesco OrioJr.Jr.. (2009) Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review. Endocrine Reviews 30:1, pages 1-50.
Crossref
Crossref
Adam H Balen. 2008. Infertility in Practice. Infertility in Practice
179
213
.
Adam H Balen. 2008. Infertility in Practice. Infertility in Practice
40
51
.
Andrew J. Krentz, Denise von Mühlen & Elizabeth Barrett-Connor. (2007) Searching for polycystic ovary syndrome in postmenopausal women. Menopause 14:2, pages 284-292.
Crossref
Crossref
Onno E. Janssen, Susanne Tan & Susanne Hahn. 2007. Insulin Resistance and Polycystic Ovarian Syndrome. Insulin Resistance and Polycystic Ovarian Syndrome
371
383
.
Enrico Carmina. 2007. Insulin Resistance and Polycystic Ovarian Syndrome. Insulin Resistance and Polycystic Ovarian Syndrome
15
24
.
Paulina A. Essah & John E. Nestler. 2007. Androgen Excess Disorders in Women. Androgen Excess Disorders in Women
273
281
.
AH Balen, P Platteau, AN Andersen, P Devroey, P Sørensen, L Helmgaard & J-C Arce. (2006) The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility. BJOG: An International Journal of Obstetrics & Gynaecology 113:10, pages 1195-1202.
Crossref
Crossref
J Lord, R Thomas, B Fox, U Acharya & T Wilkin. (2006) The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome. BJOG: An International Journal of Obstetrics & Gynaecology 113:10, pages 1203-1209.
Crossref
Crossref
Evanthia Diamanti-KandarakisDimitrios Panidis. (2016) Update on Polycystic Ovary Syndrome. Women's Health 2:4, pages 561-569.
Crossref
Crossref
J Lord, R Thomas, B Fox, U Acharya & T Wilkin. (2006) The effect of metformin on fat distribution and the metabolic syndrome in women with polycystic ovary syndrome-a randomised, double-blind, placebo-controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology 113:7, pages 817-824.
Crossref
Crossref
Leslee J. Shaw, C. Noel Bairey Merz, Carl J. Pepine, Steven E. Reis, Vera Bittner, Sheryl F. Kelsey, Marian Olson, B. Delia Johnson, Sunil Mankad, Barry L. Sharaf, William J. Rogers, Timothy R. Wessel, Christopher B. Arant, Gerald M. Pohost, Amir Lerman, Arshed A. Quyyumi & George Sopko. (2006) Insights From the NHLBI-Sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study. Journal of the American College of Cardiology 47:3, pages S4-S20.
Crossref
Crossref
Thomas Tang, Julie Glanville, Catherine J. Hayden, Davinia White, Julian H. Barth & Adam H. Balen. (2006) Combined lifestyle modification and metformin in obese patients with polycystic ovary syndrome. A randomized, placebo-controlled, double-blind multicentre study. Human Reproduction 21:1, pages 80-89.
Crossref
Crossref
Dorte Glintborg, René Klinkby Støving, Claus Hagen, Anne Pernille Hermann, Jan Frystyk, Johannes D. Veldhuis, Allan Flyvbjerg & Marianne Andersen. (2005) Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology & Metabolism 90:10, pages 5605-5612.
Crossref
Crossref
Peter Arner. (2005) Effects of testosterone on fat cell lipolysis. Species differences and possible role in polycystic ovarian syndrome. Biochimie 87:1, pages 39-43.
Crossref
Crossref
Adam Balen. (2004) The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. Best Practice & Research Clinical Obstetrics & Gynaecology 18:5, pages 685-706.
Crossref
Crossref
Leslee J. Shaw, B. Delia Johnson, Sharon Mulvagh, Jennifer H. Mieres, Rita F. Redberg & C. Noel Bairey Merz. 2004. Coronary Disease in Women. Coronary Disease in Women
173
194
.